Mode
Text Size
Log in / Sign up

Baduanjin training improves motor symptoms and anxiety more than brisk walking in Parkinson's disease

Baduanjin training improves motor symptoms and anxiety more than brisk walking in Parkinson's diseas…
Photo by CDC / Unsplash
Key Takeaway
Consider Baduanjin for motor and anxiety benefits in PD, but evidence is from a small trial.

This randomized controlled trial enrolled 32 patients with early- to mid-stage Parkinson's disease (Hoehn and Yahr stages 1–2.5) over 12 weeks. Participants were assigned to either Baduanjin training (40-minute sessions five times weekly) or brisk walking (40-minute sessions five times weekly), with outcomes assessed using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III (MDS-UPDRS-III) and other measures.

Main results showed that the Baduanjin group demonstrated significantly greater improvements in MDS-UPDRS-III scores than the brisk walking group (P < 0.05), with specific benefits on the axial subscale at 6 weeks (P = 0.038) but not at 12 weeks (P = 0.060). Baduanjin also reduced anxiety more than brisk walking (P = 0.014), improved cognition (P = 0.015), and showed superior gait parameters in Timed Up and Go duration, turning time, and trunk sagittal angular velocity (all P < 0.05). Depression improved within the Baduanjin group only (P = 0.015), while both groups improved in sleep and quality of life.

Safety and tolerability were not reported. Key limitations include the small sample size of 32 patients, and funding or conflicts of interest were not reported. Practice relevance suggests Baduanjin may offer a non-pharmacological rehabilitation option, but clinicians should consider the limited evidence and lack of safety data.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
IntroductionBaduanjin is a traditional mind-body exercise designed to modulate neural circuits and motor coordination. This study aimed to compare its rehabilitative efficacy against conventional brisk walking on postural control, motor, and non-motor functions in patients with early- to mid-stage Parkinson's disease (PD).MethodsA 12-week randomized controlled trial was conducted with 32 PD patients (Hoehn and Yahr stages 1–2.5). Participants were randomly assigned to either a Baduanjin group or a Brisk Walking group and underwent 40-min training sessions five times weekly. Primary outcomes included the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III (MDS-UPDRS-III) and Berg balance scale (BBS). Secondary outcomes included Montreal Cognitive Assessment (MoCA), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Pittsburgh Sleep Quality Index (PSQI), 39-Item Parkinson's Disease Questionnaire (PDQ-39) and objective gait parameters were quantified using wearable sensors during the Timed Up and Go (TUG) test and turning task.ResultsAfter 12 weeks, the Baduanjin group demonstrated significantly greater improvements than Brisk Walking in MDS-UPDRS-III (P < 0.05) and axial subscale improved at 6 weeks (P = 0.038) but not 12 weeks (P = 0.060). No between-group differences occurred in limb subscale or BBS (all P > 0.05).No between-group differences occurred in limb subscale or BBS (all P>0.05). Baduanjin reduced anxiety more at 12 weeks (P = 0.014) and improved cognition at 6 weeks (P = 0.015). Depression improved within Baduanjin only (P = 0.015). Both groups improved sleep and quality of life. Baduanjin showed superior gait parameters including TUG duration, turning time, trunk sagittal angular velocity during sit-to-stand/stand-to-sit; (all P < 0.05).ConclusionBaduanjin training appears to offer greater improvements in motor symptoms compared to conventional brisk walking in patients with early- to mid-stage Parkinson's disease. Its integration of mindful movement and breathing techniques may particularly address core motor deficits in PD, providing a safe, accessible, and culturally acceptable non-pharmacological rehabilitation option.Clinical Trial RegistrationChiCTR2300069360 [https://www.chictr.org.cn/].
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.